4
Changes in Ownership
Monte Rosa Therapeutics, Inc. Filed Acc 0001193125-26-290486
Chief Medical Officer sold 6,000 shares at $22.95 ($137,700)
- Chief Medical Officer acquired 6,000 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Janku Filip Chief Medical Officer | 2026-06-29 | Option exercise 10b5-1 | +6,000 | $7.56 | $45,360 | 65,992 | D: show line 1 in the form |
| Janku Filip Chief Medical Officer | 2026-06-29 | Sale 10b5-1 | −6,000 | $22.95 | $137,700 | 59,992 | D: show line 2 in the form |
| Open-market sales · 6,000 sh · avg $22.95 · $137,700 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Janku Filip Chief Medical Officer | 2026-06-29 | Option exercise · Stock Option (Right to Buy) 10b5-1 | −6,000 | 60,000 | D: show line 3 in the form |
Loading xslF345X06/ownership.xml…